What is Segami?
Founded in 1995, Segami Corporation operates as a specialized manufacturer of medical devices, specifically focusing on high-performance workstations for nuclear medicine. The company has evolved from a niche hardware provider into a comprehensive software integration partner. Its core value proposition lies in the development of customized interfaces that facilitate seamless interoperability between diagnostic workstations and existing PACS, HIS, and RIS software environments. This focus on workflow optimization ensures that clinical practitioners maintain a continuous and efficient diagnostic process, positioning Segami as a critical component in modern hospital IT ecosystems.
How much funding has Segami raised?
Segami has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Segami
PPP
Public-Private Partnership
What's next for Segami?
With the recent influx of capital, Segami is well-positioned to accelerate its product roadmap, particularly in the realm of cross-modality integration. As the healthcare industry shifts toward more unified data architectures, the company's ability to bridge the gap between legacy nuclear medicine systems and modern enterprise software will be a primary driver of growth. Future strategic initiatives will likely focus on expanding its footprint in global markets and enhancing its software-as-a-service capabilities to meet the increasing demand for cloud-integrated diagnostic tools. The firm's long-standing history provides a stable foundation for these expansion efforts, ensuring that its technological advancements remain aligned with the evolving needs of clinical radiology departments worldwide.
See full Segami company page
